This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schifano, F. Search for Related Content PubMed PubMed Citation Articles by Schifano, F. Social Bookmarking                         What's this?

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (‘Blue Mystic’)

Division of Mental Health - Addictive Behaviour, St George’s Hospital Medical School, University of London, London, UK, fschifan{at}sgul.ac.uk

Paolo Deluca

Division of Mental Health - Addictive Behaviour, St George’s Hospital Medical School, University of London, London, UK

Lisa Agosti

Division of Mental Health - Addictive Behaviour, St George’s Hospital Medical School, University of London, London, UK

Giovanni Martinotti

Department of Psychiatry, Catholic University, Rome, Italy

John M. Corkery

Division of Mental Health - Addictive Behaviour, St George’s Hospital Medical School, University of London, London, UK

The Psychonaut 2002 Research Group

2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-intoxication with 2C-T-7 has been documented in the USA. With respect to information on 2C-T-7 available online, due to both redundancy and relevance issues the initial identified sample of 360 was reduced to 118 websites. In 14 (11.9%) websites, the detailed description of the 2C-T-7 synthesis was given. Harm Reduction websites appeared significantly earlier in the search engines results’ list than Anti drugs (p 0.006) websites. Five (4.2%) websites apparently offered 2C-T-7 for sale. The large body of knowledge available online seems to contrast with small numbers of seizures at street level; an exhaustive web mapping of drug-related issues may be of interest for the clinician. Projects aimed at designing more ‘attractive’ prevention websites should be planned and future studies should better assess the characteristics of those consumers who take advantage of the online information of hallucinogenic compounds.

Key Words: 2C-T-7 • phenethylamines • hallucinogens • MDMA • ecstasy • drug abuse • Internet • online sales • drug abuse prevention • designer drugs

Journal of Psychopharmacology, Vol. 19, No. 6, 675-679 (2005)
DOI: 10.1177/0269881105056660


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J.-X. Li, K. C. Rice, and C. P. France Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 827 - 833. [Abstract] [Full Text] [PDF]